An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder

Wayne A. Hening, Richard P. Allen, Christopher J. Earley, Daniel L. Picchietti, Michael H. Silber

Research output: Contribution to journalReview article

Abstract

This paper reviews evidence from April, 1998 through April 2002 for the dopaminergic treatment of the restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). There has been increased study of dopaminergic agents for the treatment of these conditions since publication of a review paper and practice parameters that covered all types of medical treatment of RLS and PLMD in 1999. For this reason, the Restless Legs Syndrome Task Force and the Standards of Practice Committee decided to update the evidence on dopaminergic treatment of these conditions. This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline).

Original languageEnglish (US)
Pages (from-to)560-583
Number of pages24
JournalSleep
Volume27
Issue number3
DOIs
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Nocturnal Myoclonus Syndrome
Restless Legs Syndrome
Dopamine Agents
Pergolide
Selegiline
Amantadine
Dopamine Agonists
Levodopa
Advisory Committees
Publications

ASJC Scopus subject areas

  • Clinical Neurology
  • Physiology (medical)

Cite this

An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. / Hening, Wayne A.; Allen, Richard P.; Earley, Christopher J.; Picchietti, Daniel L.; Silber, Michael H.

In: Sleep, Vol. 27, No. 3, 01.01.2004, p. 560-583.

Research output: Contribution to journalReview article

Hening, Wayne A. ; Allen, Richard P. ; Earley, Christopher J. ; Picchietti, Daniel L. ; Silber, Michael H. / An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. In: Sleep. 2004 ; Vol. 27, No. 3. pp. 560-583.
@article{53a85d30606e46b1a2f8d10ea4ffaeff,
title = "An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder",
abstract = "This paper reviews evidence from April, 1998 through April 2002 for the dopaminergic treatment of the restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). There has been increased study of dopaminergic agents for the treatment of these conditions since publication of a review paper and practice parameters that covered all types of medical treatment of RLS and PLMD in 1999. For this reason, the Restless Legs Syndrome Task Force and the Standards of Practice Committee decided to update the evidence on dopaminergic treatment of these conditions. This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline).",
author = "Hening, {Wayne A.} and Allen, {Richard P.} and Earley, {Christopher J.} and Picchietti, {Daniel L.} and Silber, {Michael H.}",
year = "2004",
month = "1",
day = "1",
doi = "10.1093/sleep/27.3.560",
language = "English (US)",
volume = "27",
pages = "560--583",
journal = "Sleep",
issn = "0161-8105",
publisher = "American Academy of Sleep Medicine",
number = "3",

}

TY - JOUR

T1 - An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder

AU - Hening, Wayne A.

AU - Allen, Richard P.

AU - Earley, Christopher J.

AU - Picchietti, Daniel L.

AU - Silber, Michael H.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - This paper reviews evidence from April, 1998 through April 2002 for the dopaminergic treatment of the restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). There has been increased study of dopaminergic agents for the treatment of these conditions since publication of a review paper and practice parameters that covered all types of medical treatment of RLS and PLMD in 1999. For this reason, the Restless Legs Syndrome Task Force and the Standards of Practice Committee decided to update the evidence on dopaminergic treatment of these conditions. This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline).

AB - This paper reviews evidence from April, 1998 through April 2002 for the dopaminergic treatment of the restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). There has been increased study of dopaminergic agents for the treatment of these conditions since publication of a review paper and practice parameters that covered all types of medical treatment of RLS and PLMD in 1999. For this reason, the Restless Legs Syndrome Task Force and the Standards of Practice Committee decided to update the evidence on dopaminergic treatment of these conditions. This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline).

UR - http://www.scopus.com/inward/record.url?scp=1542264478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542264478&partnerID=8YFLogxK

U2 - 10.1093/sleep/27.3.560

DO - 10.1093/sleep/27.3.560

M3 - Review article

C2 - 15164915

AN - SCOPUS:1542264478

VL - 27

SP - 560

EP - 583

JO - Sleep

JF - Sleep

SN - 0161-8105

IS - 3

ER -